An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice - Wikidata - wikimedia - TriplyDB

An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice

An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice

http://www.wikidata.org/entity/Q24561588

about

Targeting the hepatocyte growth factor-cMET axis in cancer therapy Genetic targeting of the kinase activity of the Met receptor in cancer cells Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins Biology of MET: a double life between normal tissue repair and tumor progression MET molecular mechanisms and therapies in lung cancer Drug development against metastasis-related genes and their pathways: A rationale for cancer therapy Engineering hepatocyte growth factor fragments with high stability and activity as Met receptor agonists and antagonists.Inhibition of the MET Receptor Tyrosine Kinase as a Novel Therapeutic Strategy in Medulloblastoma Structural basis of hepatocyte growth factor/scatter factor and MET signalling.The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist Targeting the HGF/Met signalling pathway in cancer.Biological properties of ligand-dependent activation of the MET receptor kinase in acute myeloid leukemia.Direct binding of hepatocyte growth factor and vascular endothelial growth factor to CD44v6.Targeting the HGF-cMET Axis in Hepatocellular Carcinoma.A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met Inhibition of c-Met reduces lymphatic metastasis in RIP-Tag2 transgenic mice Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis.Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.MET as a target for treatment of chest tumors Biochemical basis for the functional switch that regulates hepatocyte growth factor receptor tyrosine kinase activation Targeting the Met signaling pathway in renal cancer.Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion Targeted therapy for malignant glioma patients: lessons learned and the road ahead.Clinical implications of MET gene copy number in lung cancer.Selection criteria for c-Met-targeted therapies: emerging evidence for biomarkers.C-MET as a new therapeutic target for the development of novel anticancer drugs.Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.Targeting the MET oncogene in cancer and metastases.Progress in cancer therapy targeting c-Met signaling pathway.Targeting met mediated epithelial-mesenchymal transition in the treatment of breast cancer.Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment.Radiofrequency ablation suppresses distant tumour growth in a novel rat model of multifocal hepatocellular carcinoma.HGF-MET cascade, a key target for inhibiting cancer metastasis: the impact of NK4 discovery on cancer biology and therapeutics.Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth.Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling.Metron factor-1 prevents liver injury without promoting tumor growth and metastasis.Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma.Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation.An engineered dimeric fragment of hepatocyte growth factor is a potent c-MET agonist.

P2860

Q24606259-3F5157B2-0AF3-4F31-8488-34F49D499DC5 Q24675200-1096EEA8-2924-4890-BFE5-7525EFE62D88 Q28077999-114011DD-850E-4ABC-BD57-6F6F6926C577 Q28085247-FBC2A87A-6D9A-4649-AF20-6E5035DF1BD8 Q28272688-0414EB4B-D988-435F-9C8D-0E7C27E931A0 Q29010479-D3C73925-DD3D-4C92-AEC1-6EC3D7B77667 Q33970874-31D3118D-AED5-4C54-9A5D-836AC0DF5918 Q34398276-2CB548D1-0BB7-493D-8C96-D8E21FB151D9 Q34572895-4EF0FB02-D996-4E54-8EE5-DF71B2251AC7 Q35563524-F6928857-9C5A-4C58-AF7B-D92F3F8B62AB Q35689753-3BD270A1-7F87-4238-81AD-1CC78C226BCB Q36142604-638A20F7-4AB7-412D-ADB2-FA9CDDB1A931 Q36263622-BB607010-4ECE-4084-BB61-5E36F6A9BDCE Q36487012-CDFF4B69-2E08-4A51-AA0D-AF67DA2C238E Q36766188-1A980EFE-03AD-4A61-A18A-81D252A646B0 Q36777999-4FF35CC0-6531-4D13-8CE9-26FF19583442 Q36941168-D824C4A1-97BE-4352-A2B3-217D54D85EE3 Q37143367-2AB6B4B8-B966-48DC-B0BD-FE9DE1E816D4 Q37223558-615CCBB7-5D81-45FD-BB42-7BC78258D69A Q37232416-62F2EC41-7D1F-4A96-92CA-AEBDA62BDD61 Q37312433-B55F450A-4D56-4D0E-B190-DC5E18A910A9 Q37331862-40EA9CF1-CDD7-4156-B5C6-F426D18F67B7 Q37340100-98EDC0C8-2B80-4587-914C-405A30C1E72E Q37533648-64A0097B-76F2-4BC7-BB89-1019006A3C78 Q37690299-83DB68E8-C624-492A-9FB3-E8C5D1FFE3B6 Q37730020-CBFEEC5E-1B9C-4E40-8E09-76854B766724 Q37750050-5BF2DD73-2DD2-49BF-B107-AFB7E2B58F49 Q37774602-13260686-9253-4353-9064-9573C8BB0FDD Q37792116-9EC4E40B-E98D-4E3C-8AB9-B3BB22B6DDB6 Q38007133-DB93899C-D60E-4ED5-80DC-1B69917CADAE Q38757070-F5CCD0A7-5BB2-48C7-BB48-21F5C21802FB Q38831784-633EA98C-4F6F-4D8E-AEED-FEE224DEBC53 Q39131172-55D4436A-01F3-4334-A2C4-E105180F9500 Q39214964-8188E641-49A3-4E86-BC2A-B5F290D8B7CC Q39684133-974CC186-2E37-420C-B5C3-8B796DAEC0C5 Q39816968-41A371C9-151F-4E97-8FD6-BDEE1EC925B9 Q39978074-2CBECCA8-2D28-43D7-981C-A5B82677B914 Q40203442-C41FD7B3-D675-4FDE-859F-1A472EB375B1 Q41825773-62C5A7EB-453F-4914-86D5-429216F14533 Q42088207-A566497B-8987-4D56-B1FB-AD4C8A67A50A

P2860

An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice

http://www.wikidata.org/entity/Q24561588

description

2004 nî lūn-bûn

@nan

2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

An uncleavable form of pro-sca ...... owth and dissemination in mice

@ast

An uncleavable form of pro-sca ...... owth and dissemination in mice

@en

An uncleavable form of pro-sca ...... owth and dissemination in mice

@nl

type

label

An uncleavable form of pro-sca ...... owth and dissemination in mice

@ast

An uncleavable form of pro-sca ...... owth and dissemination in mice

@en

An uncleavable form of pro-sca ...... owth and dissemination in mice

@nl

prefLabel

An uncleavable form of pro-sca ...... owth and dissemination in mice

@ast

An uncleavable form of pro-sca ...... owth and dissemination in mice

@en

An uncleavable form of pro-sca ...... owth and dissemination in mice

@nl

P1433

Q24561588-DD202756-0A5D-481A-919C-E203CEF73A62

P1476

Q24561588-73735F76-9CB9-485E-9AA5-E582274AA78D

P2093

Q24561588-1A756412-7A2A-4836-9AE5-34583F5D75C2

Q24561588-22BE228B-8303-4C3E-9623-1033E74646BD

Q24561588-23853D7B-219C-4924-B5CD-8FE15332B4C9

Q24561588-2656262B-0D13-4510-9CF7-65CCD7298359

Q24561588-35438ACD-8611-45D6-B68F-6E871F7166BE

Q24561588-35ADC170-ABD9-429D-968A-2710E8368E74

Q24561588-5FFB9CDF-D135-4FBB-BE5A-827BCBCECCA2

P2860

Q24561588-051B5848-D4C0-4223-B709-BEA0ABE1F7E9

Q24561588-063F9024-77B0-4E15-9233-4C8941C0A3E2

Q24561588-07FEAF48-92C5-434A-B58F-EEB27ED54A06

Q24561588-0A28D8FA-CFAE-421E-B9F2-1A7B68B0894E

Q24561588-188FAC99-EF4C-4410-ACB6-5BFF7079EF03

Q24561588-19A8AA86-39DC-476F-A8C4-58ECB57E4FAA

Q24561588-1BB4493F-3DF4-46F7-A2E4-9EA9D807611A

Q24561588-1C08FA11-2538-4673-B102-9CD337D43BEA

Q24561588-1C6803D3-C984-464C-9B87-E0BC3E530EC5

Q24561588-1E95E28E-E9E7-4142-B0A0-85EF2BA0B86C

P304

Q24561588-530182D1-FFAC-46AA-866F-8C5FA73C18AB

P31

Q24561588-79F8739F-BF41-46F7-8EF7-D954EAA37B7F

P3181

Q24561588-23F9A46B-EBD6-4ADE-865B-8DCF0F2A5FA7

P356

Q24561588-939541DE-4321-40AC-A743-11FBFEF3F704

P407

Q24561588-3D7880AC-CE59-4C95-90CF-FCDFA2D2849A

P433

Q24561588-3E5C4C6D-9372-4FDE-A9E3-C42345845EA1

P478

Q24561588-08E7BBB9-901A-4298-A336-997B3D4E2016

P50

Q24561588-468D15C0-2BDE-4FD4-AF01-92C372771B6A

P577

Q24561588-CCDBD600-60A4-4572-A349-D9B2831FA65E

P5875

Q24561588-B29188C1-C19C-4EE5-9EC8-2679B26DBA77

P698

Q24561588-CAB284CA-84E0-4DBB-91CD-FC07CE7C4017

P932

Q24561588-DD074624-C18B-48D1-8AA3-96F30211D3E3

P3181

P356

P1433

Journal of Clinical Investigation

P1476

An uncleavable form of pro-sca ...... owth and dissemination in mice

@en

P2093

Cristina Basilico

http://www.w3.org/2001/XMLSchema#string

Massimiliano Mazzone

http://www.w3.org/2001/XMLSchema#string

Mauro Risio

http://www.w3.org/2001/XMLSchema#string

Paolo M Comoglio

http://www.w3.org/2001/XMLSchema#string

Paolo Michieli

http://www.w3.org/2001/XMLSchema#string

Selma Pennacchietti

http://www.w3.org/2001/XMLSchema#string

Silvia Cavassa

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor

Activation of the zymogen of hepatocyte growth factor activator by thrombin

Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor

Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor

Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models

Disruption of epithelial cell-matrix interactions induces apoptosis

NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

Unusual proteolytic activation of pro-hepatocyte growth factor by plasma kallikrein and coagulation factor XIa

Met, metastasis, motility and more

P304

1418-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3316490

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI22235

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8181051

http://www.w3.org/2001/XMLSchema#string

P698

15545993

http://www.w3.org/2001/XMLSchema#string

P932

525743

http://www.w3.org/2001/XMLSchema#string